← PFIZER INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $52.8b $52.5b $53.6b $51.8b $41.9b $81.3b $100.3b $50.9b $63.6b $62.6b
Cost of Revenue $12.3b $11.2b $11.2b $10.2b $8.7b $30.8b $34.3b $25.0b $17.9b $16.1b
Cost of sales $12.3b $11.2b $11.2b $10.2b $8.7b $30.8b $34.3b $25.0b $17.9b $16.1b
Gross Profit (Calculated) $40.5b $41.3b $42.4b $41.5b $33.2b $50.5b $66.0b $26.0b $45.8b $46.5b
Additional Financial Items
Alliance revenues — — — — — $7.7b $8.5b $7.6b $8.4b $9.3b
Amortization of Intangible Assets $4.1b $4.8b $4.9b $4.6b $3.4b $3.7b $3.6b $4.7b $5.3b $4.9b
Debt Securities, Realized Gain (Loss) — — ($141.0m) $0 $0 — — — — —
Discontinued operations––net of tax $17.0m $2.0m $10.0m $4.0m $2.6b ($434.0m) $6.0m ($15.0m) $11.0m $25.0m
Equity Securities, FV-NI, Realized Gain (Loss) — — $109.0m $25.0m $24.0m $80.0m $126.0m $1.8b $1.1b ($35.0m)
Gain (Loss) Related to Litigation Settlement — ($240.0m) ($157.0m) ($554.0m) ($28.0m) ($182.0m) ($230.0m) ($474.0m) ($567.0m) ($1.1b)
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($8.5b) ($6.9b) ($4.4b) $7.9b ($2.5b) $6.1b $5.0b ($4.4b) ($637.0m) $776.0m
Income (Loss) from Continuing Operations, Per Basic Share $1 $4 $2 $3 $1 $4 $6 $0 $1 $1
Income (Loss) from Continuing Operations, Per Diluted Share $1 $4 $2 $3 $1 $4 $5 $0 $1 $1
Income from continuing operations $7.2b $21.4b $11.2b $16.3b $7.0b $22.5b $31.4b $2.2b $8.1b $7.8b
Income from continuing operations before provision/(benefit) for taxes on income $8.4b $12.3b $11.9b $17.7b $7.5b $24.3b $34.7b $1.1b $8.0b $7.5b
Other (income)/deductions––net $3.7b $1.3b $2.1b $3.6b $669.0m ($4.9b) $217.0m ($835.0m) $4.4b $6.7b
Preferred Stock Dividends, Income Statement Impact $1.0m $1.0m $1.0m $1.0m $0 $0 — — — —
Provision/(benefit) for taxes on income $1.1b ($9.0b) $706.0m $1.4b $477.0m $1.9b $3.3b ($1.1b) ($28.0m) ($266.0m)
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax $16.0m ($1.0m) $10.0m $4.0m — — — — — —
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $8.4b $12.3b $11.9b $17.7b $7.5b $24.3b $34.7b $1.1b $8.0b $7.5b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $7.2b $21.3b $11.1b $16.3b $7.0b $22.4b — — — —
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $7.2b $21.4b $11.2b $16.3b $7.0b $22.5b $31.4b $2.2b $8.1b $7.8b
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $17.0m $2.0m $10.0m $4.0m $2.6b ($434.0m) $6.0m ($15.0m) $11.0m $25.0m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $17.0m $2.0m $10.0m $4.0m $2.6b ($434.0m) $6.0m ($15.0m) $11.0m $25.0m
Net Income (Loss) Attributable to Parent $7.2b $21.3b $11.2b $16.3b $9.6b $22.0b $31.4b $2.1b $8.0b $7.8b
Net Income (Loss) Available to Common Stockholders, Basic $7.2b $21.3b $11.2b $16.3b $9.6b $22.0b $31.4b $2.1b $8.0b $7.8b
Less: Net income attributable to noncontrolling interests $31.0m $47.0m $36.0m $29.0m $36.0m $45.0m $35.0m $39.0m $31.0m $41.0m
Net Income (Loss) Attributable to Noncontrolling Interest $31.0m $47.0m $36.0m $29.0m $36.0m $45.0m $35.0m $39.0m $31.0m $41.0m
Net income before allocation to noncontrolling interests $7.2b $21.4b $11.2b $16.3b $9.7b $22.0b $31.4b $2.2b $8.1b $7.8b
Common Stock, Dividends, Per Share, Declared $1.08 $1.15 $1.31 $1.39 $1.53 $1.57 $1.61 $1.65 $1.69 $1.72
Discontinued operations––net of tax (in dollars per share) $0.00 $0.00 $0.00 $0.00 $0.47 ($0.08) $0.00 $0.00 $0.00 $0.00
Earnings Per Share, Basic $1.12 $3.39 $1.80 $2.77 $1.73 $3.92 $5.59 $0.38 $1.42 $1.37
Earnings Per Share, Diluted $1.11 $3.34 $1.77 $2.72 $1.71 $3.85 $5.47 $0.37 $1.41 $1.36
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) $1 $4 $2 $3 $1 $4 $5 $0 $1 $1
Weighted Average Number of Shares Outstanding, Basic 6.4b 6.3b 6.2b 5.9b 5.6b 5.6b 5.6b 5.6b 5.7b 5.7b
Weighted-average shares––basic (in shares) $6.1b $6.0b $5.9b $5.6b $5.6b $5.6b $5.6b $5.6b $5.7b $5.7b
Weighted-average shares––diluted (in shares) $6.2b $6.1b $6.0b $5.7b $5.6b $5.7b $5.7b $5.7b $5.7b $5.7b
Weighted Average Number of Shares Outstanding, Diluted 6.5b 6.4b 6.3b 6.0b 5.6b 5.7b 5.7b 5.7b 5.7b 5.7b
Acquired in-process research and development expenses — — — — $684.0m $3.5b $953.0m $194.0m $108.0m $1.6b
Current Income Tax Expense (Benefit) — — — — — — — — — $1.9b
Interest Expense $1.2b $1.3b $1.3b $1.6b $1.4b $1.3b $1.2b $2.2b $3.1b $2.7b
Other Nonoperating Income (Expense) ($3.7b) ($1.3b) ($2.1b) ($3.6b) ($669.0m) $4.9b ($217.0m) $835.0m ($4.4b) ($6.7b)
Research and development expenses $7.9b $7.7b $8.0b $8.7b $9.4b $13.8b $11.4b $10.7b $10.8b $10.4b
Restructuring and Related Cost, Incurred Cost — — $1.4b $967.0m — — — — — —
Restructuring charges and certain acquisition-related costs $1.7b $487.0m $1.0b $747.0m $600.0m $802.0m $1.4b $2.9b $2.4b $1.6b
Selling, General and Administrative Expense $14.8b $14.8b $14.5b $14.3b $11.6b $12.7b $13.7b $14.8b $14.7b $13.8b
Selling, informational and administrative expenses $14.8b $14.8b $14.5b $14.3b $11.6b $12.7b $13.7b $14.8b $14.7b $13.8b
Income Tax Expense (Benefit) $1.1b ($9.0b) $706.0m $1.4b $477.0m $1.9b $3.3b ($1.1b) ($28.0m) ($266.0m)
Interest Revenue (Expense), Net ($716.0m) ($879.0m) ($983.0m) ($1.3b) ($1.4b) ($1.3b) ($987.0m) ($585.0m) ($2.5b) ($2.1b)
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component — — ($288.0m) $64.0m ($236.0m) ($2.5b) ($849.0m) ($610.0m) $154.0m ($678.0m)

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.